Bone Biologics (BBLG) Interest Coverage Ratio (2014 - 2025)
Bone Biologics (BBLG) posted quarterly Interest Coverage Ratio of 8.3 for Q4 2025, up 53.6% year-over-year from 5.4 in Q4 2024, and down 181.13% quarter-over-quarter from 2.95 in Q3 2025.
Powered by 
Analysis
Bone Biologics (BBLG) Interest Coverage Ratio (2014 - 2025) Analysis & Trends
Bone Biologics (BBLG) has reported Interest Coverage Ratio for 13 consecutive years, with 8.3 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 53.6% year-over-year to 8.3; the TTM figure through Dec 2025 stood at 9.78 (up 79.84% YoY), while the FY2025 annual figure was 0.13, up 33.0% from the prior year.
- Interest Coverage Ratio retreated to 8.3 in Q4 2025 per BBLG's latest filing, from 2.95 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.59 in Q4 2021 and bottomed at 3003.38 in Q1 2023.
- Historically, Interest Coverage Ratio has averaged 249.91 across 5 years, with a median of 2.95 in 2025.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio soared 170.87% — and 2024, when it plunged 31373.26%.
- Bone Biologics' Interest Coverage Ratio stood at 0.59 in 2021, then sank by 110.69% to 0.06 in 2022, then increased by 10.13% to 0.06 in 2023, then slumped by 31373.26% to 17.89 in 2024, then surged by 53.6% to 8.3 in 2025.
- Business Quant data shows BBLG's Interest Coverage Ratio at 8.3 in Q4 2025, 2.95 in Q3 2025, and 17.89 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 1.42 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.08 |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -8.30 |
| Sep 30, 2025 | -2.95 |
| Dec 31, 2024 | -17.89 |
| Sep 30, 2024 | -3.27 |
| Dec 31, 2021 | -31.21 |
| Sep 30, 2021 | -0.82 |
| Jun 30, 2021 | -0.89 |
| Mar 31, 2021 | -0.72 |
| Dec 31, 2020 | -0.83 |
| Sep 30, 2020 | -0.59 |
| Jun 30, 2020 | -0.54 |
| Mar 31, 2020 | -1.33 |
| Dec 31, 2019 | -1.09 |
| Sep 30, 2019 | -1.16 |
| Jun 30, 2019 | -2.78 |
| Mar 31, 2019 | -5.47 |
| Dec 31, 2018 | -5.35 |
| Sep 30, 2018 | 1.70 |
| Jun 30, 2018 | -2.14 |
| Mar 31, 2018 | -3.06 |